|
End-of-day quote
Korea S.E.
14/08/2026
|
5-day change | 1st Jan Change | ||
| 4,620.00 KRW | +3.59% |
|
+28.33% | -32.85% |
| 14/04 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 03/04 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.59% | +28.33% | +17.41% | -33.04% | -32.85% | +70.79% | -39.13% | -77.73% | - | 165M | |
| -1.78% | -0.71% | -4.42% | +18.64% | +4.61% | +2.18% | +13.68% | -22.10% | +198.46% | 49.24B | |
| +0.85% | +2.98% | +10.74% | +35.86% | +155.76% | +464.76% | +579.26% | +696.99% | - | 43.3B | |
| -2.40% | +5.36% | +14.32% | +9.77% | +14.37% | +13.00% | +75.78% | +25.81% | +1,134.39% | 40.48B | |
| -2.01% | +1.82% | +14.03% | +37.29% | +4.99% | +24.41% | +7.65% | -4.63% | +209.76% | 39.75B | |
| -0.50% | +3.08% | +14.79% | +10.79% | +16.60% | +19.91% | +47.26% | -11.26% | +153.13% | 32.67B | |
| +0.38% | -1.08% | -6.81% | +1.47% | - | - | - | - | - | 16.23B | |
| -0.59% | -1.11% | +9.11% | +36.52% | +3.00% | +23.61% | +116.76% | +225.57% | +1,963.12% | 16.24B | |
| +0.49% | +0.80% | +1.35% | +19.76% | +12.88% | +5.45% | +22.29% | -38.08% | +85.05% | 14.04B | |
| -0.43% | +5.48% | +21.89% | +71.97% | +40.39% | +80.68% | +30.58% | -31.90% | +237.74% | 13.43B | |
| -2.59% | +1.23% | -1.78% | +38.99% | -10.47% | -7.45% | -36.86% | -31.75% | +113.02% | 12.92B | |
| -1.37% | +24.04% | +44.13% | +79.86% | +72.78% | +59.27% | +66.51% | -46.61% | - | 12.3B | |
| +0.31% | +0.69% | +1.45% | +61.27% | +23.10% | +32.32% | -14.21% | -37.98% | +161.14% | 11.25B | |
| -3.66% | -6.81% | -14.49% | -2.10% | -14.70% | +72.03% | +523.18% | +283.93% | +2,288.37% | 10.6B | |
| -0.45% | -0.91% | +16.61% | +5.76% | +24.45% | +647.83% | +2,123.09% | +77.20% | - | 10.29B | |
| +0.07% | +0.04% | +0.55% | +60.29% | +78.26% | +260.14% | +520.90% | - | - | 10.14B | |
| -4.23% | +12.74% | -7.04% | +13.28% | -11.95% | -25.33% | - | - | - | 9.8B | |
| +2.43% | +6.10% | +19.41% | +49.31% | +77.58% | +173.45% | +720.20% | +225.23% | +1,240.54% | 9.8B | |
| +2.60% | +10.32% | +6.33% | +37.15% | +50.87% | +188.22% | +485.49% | +117.63% | - | 9.51B | |
| +2.45% | +5.05% | +0.86% | -26.24% | -27.65% | +32.81% | +42.32% | +44.25% | +63.40% | 9.28B | |
| Average | -0.32% | +3.34% | +7.92% | +26.33% | +25.37% | +112.53% | +293.60% | +82.03% | +654.01% | 18.57B | |
| Weighted average by Cap. | -0.83% | +2.83% | +8.00% | +27.20% | +33.33% | +108.50% | +226.41% | +114.54% | +560.57% |
- Stock Market
- Stocks
- A314130 Stock
- Sector Genome & Company
Select your edition
All financial news and data tailored to specific country editions
